Aimmed’s Insomnia App Approved As Korea’s First Digital Therapeutic
But Reimbursement Decision May Take Time
More approvals of digital therapeutics are expected to come in the wake of South Korea's first approval of this type of product, Aimmed’s insomnia mobile app Somzz. But reimbursement decisions on such therapies could take months and will be closely monitored going forward.
